ArticleJournal of multidisciplinary healthcare2025
Mapping the Colorectal Cancer Patient Journey From the Oncologist Perspective in Saudi Arabia.
Article in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Mapping the colorectal cancer (CRC) patient pathway is needed to identify knowledge gaps and improve patient care. We aimed to understand the medical journey of patients and the role of the multidisciplinary team (MDT) in managing CRC in Saudi Arabia. Methods: A nationwide survey was administered to healthcare professionals (HCPs) in Saudi Arabia during August 1-September 15, 2024, to characterize typical patient profiles and CRC management. Results: Out of 33 responses, 28 were eligible, mostly were medical oncologists (96.4%) in tertiary healthcare settings (>85%) with 5-20 years of experience (78.6%). Most HCPs reported that patients had no or limited awareness of CRC (89.3%) and lacked access to support groups (71.4%). The guideline-recommended screening of individuals aged 45-75 years with no symptoms or a family history of CRC or polyps was only reported by 67.9% of respondents. Common screening methods were colonoscopy (89.3%) and fecal immunochemical test (53.6%). Major barriers to optimal CRC screening were patients' lack of awareness (92.9%) and challenges in accessing screening programs (75.0%). Gastroenterologists were the primary referrers to specialized centers and were responsible for diagnosing CRC (reported by 92.9% and 85.7%, respectively); 53.6% and 17.9% of respondents reported that surgical oncologists and an MDT also made the definitive diagnosis, respectively. Respondents identified the key MDT members taking care of patients with CRC as surgical (100.0%), medical (100.0%), radiation oncologists (92.9%), and pathologists (92.9%). Some MDTs involved other professionals, including radiologists (85.7%), clinical gastroenterologists (64.3%), dieticians (64.3%) and pharmacists (60.7%). The most common barrier to effective CRC treatment was delays in patient presentation (67.9%). Conclusion: The results give clinicians and public bodies the opportunity to address critical factors for improving the outcomes for CRC patients in Saudi Arabia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.